Adjuvant Tegafur-Uracil Improves Survival in Low-Risk, Mismatch Repair Proficient Stage IIA Colon Cancer: A Propensity Score-Matched Analysis

<b>Background</b>: The benefit of adjuvant chemotherapy for low-risk, mismatch repair proficient (pMMR) stage IIA colon cancer is uncertain. Surveillance is standard, but some patients relapse. Tegafur-uracil (UFT) is a low-toxicity oral option that may offer benefit; <b>Methods</b>: This retrospect...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Min-Chi Cheng, Hsu-Lin Lee, Shiue-Wei Lai, Jia-Hong Chen, Po-Huang Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-12-01
coleção:	Life
Assuntos:	colon cancer tegafur-uracil (UFT) adjuvant chemotherapy mismatch repair proficient (pMMR) propensity score matching
Acesso em linha:	https://www.mdpi.com/2075-1729/15/12/1930
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!